CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue:
Total revenue	$ 3,180,187	$ 4,492,978
Cost of revenue:
Total cost of revenue	547,380	643,414
Gross profit	2,632,807	3,849,564
Operating expenses:
Research and development costs	674,924	947,384
Selling and marketing	981,191	1,040,289
General and administrative	1,093,169	1,476,296
Restructuring costs	287,460	157,693
Total operating expenses	3,036,744	3,621,662
Operating income (loss)	(403,937)	227,902
Interest and other expense	(245,839)	(265,223)
Loss before income taxes	(649,776)	(37,321)
Income tax expense	70,064	87,586
Net loss	(719,840)	(124,907)
Less: Accrual of Series A redeemable convertible preferred stock dividends	285,760	247,027
Less: Accretion to redemption value of Series A redeemable convertible preferred stock	26,090	129,239
Net loss attributable to common stockholders	$ (1,031,690)	$ (501,173)
Basic net loss per share attributable to common stockholders (in dollars per share)	$ (0.17)	$ (0.09)
Diluted net loss per share attributable to common stockholders (in dollars per share)	$ (0.17)	$ (0.09)
Weighted average basic shares outstanding (in shares)	5,919,643	5,887,988
Weighted average diluted shares outstanding (in shares)	5,919,643	5,887,988
Product revenue
Revenue:
Total revenue	$ 1,048,963	$ 1,745,784
Cost of revenue:
Total cost of revenue	139,460	79,669
Support and services revenue
Revenue:
Total revenue	2,131,224	2,747,194
Cost of revenue:
Total cost of revenue	$ 407,920	$ 563,745